BusinessProQR Completes Dosing of Cystic Fibrosis Patients in QR-010 Phase 1b TrialBy Nasdaq OMXAug 29, 2017, 11:00 AM UTC
BusinessTempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical TrialBy Nasdaq OMXAug 17, 2017, 1:00 PM UTC
BusinessMYnd Analytics, Horizon Healthcare Services, Inc., Hackensack Meridian Health and Cota Inc., Announce Collaboration to Demonstrate Clinical Utility and Cost Savings When Utilizing the Peer Online®By Nasdaq OMXAug 16, 2017, 11:30 AM UTC
BusinessAnthera Pharmaceuticals Provides Business Update and Reports 2017 Second Quarter Financial ResultsBy Nasdaq OMXAug 9, 2017, 12:30 PM UTC
BusinessAchillion Reports Second Quarter 2017 Financial Results and Proof-of-Concept With a First-in-Class, Oral Factor D InhibitorBy Nasdaq OMXAug 8, 2017, 8:02 PM UTC
BusinessMYnd Analytics Adds Experienced Sales & Marketing ExecutiveBy Nasdaq OMXAug 4, 2017, 2:10 PM UTC
BusinessAXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related PsychosisBy Nasdaq OMXAug 2, 2017, 1:01 PM UTC
